Actively Recruiting

Age: 18Years +
All Genders
NCT06181994

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Led by Montefiore Medical Center · Updated on 2026-01-07

5000

Participants Needed

19

Research Sites

138 weeks

Total Duration

On this page

Sponsors

M

Montefiore Medical Center

Lead Sponsor

G

Geisinger Clinic

Collaborating Sponsor

AI-Summary

What this Trial Is About

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

CONDITIONS

Official Title

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients 18 years of age or older
  • Underwent endovascular embolization of middle meningeal artery using materials such as PVA particles, Onyx, nBCA glue, dimethyl sulfoxide, microcoils, or PVA with microcoils
Not Eligible

You will not qualify if you...

  • Received endovascular embolization of middle meningeal artery using any embolization material other than those specified in the inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 19 locations

1

Baptist Health South Florida, Inc.

Coral Gables, Florida, United States, 33143

Actively Recruiting

2

Mayo Clinic Florida

Jacksonville, Florida, United States, 32224

Completed

3

Orlando Regional Medical Center

Orlando, Florida, United States, 32806

Actively Recruiting

4

University of Illinois Chicago

Chicago, Illinois, United States, 60607

Completed

5

University of Chicago Medicine

Chicago, Illinois, United States, 60637

Actively Recruiting

6

The University of Iowa

Iowa City, Iowa, United States, 52242

Completed

7

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

8

Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School

Boston, Massachusetts, United States, 02215

Actively Recruiting

9

Lahey Hospital and Medical Center

Burlington, Massachusetts, United States, 01805

Actively Recruiting

10

Mayo Clinic

Rochester, Minnesota, United States, 55905

Completed

11

Montefiore Medical Center

The Bronx, New York, United States, 10467

Actively Recruiting

12

Geisinger Health

Danville, Pennsylvania, United States, 17822

Completed

13

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19144

Actively Recruiting

14

UTHealth Houston

Houston, Texas, United States, 77030

Completed

15

HCA Houston Healthcare Kingwood

Kingwood, Texas, United States, 77339

Completed

16

Austin Health

Heidelberg, Victoria, Australia, 3084

Actively Recruiting

17

Unity Health Toronto

Toronto, Ontario, Canada, M5C 2T2

Completed

18

University of Toronto

Toronto, Ontario, Canada, M5S 1A1

Actively Recruiting

19

Toronto Western Hospital

Toronto, Ontario, Canada, M5T 2S8

Completed

Loading map...

Research Team

M

Muhammed Amir Essibayi, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here